New York, New York (PRWEB) May 28, 2014
Thousands of transvaginal mesh lawsuits (http://www.injurybeacon.com/transvaginal-mesh/lawsuit/) filed against Boston Scientific Corp. continue to move forward in a federal multidistrict litigation underway in U.S. District Court, Southern District of West Virginia, Bernstein Liebhard LLP reports. According to an Order dated May 27th, the Court has established deadlines, criteria and other requirements pertaining to discovery in the litigation’s first bellwether trials. Among other things, the Order stipulates that fact discovery for “Wave 1” bellwether cases is to be completed by August 4, 2014, while the deadline for completing fact discovery for “Wave 2” is October 3, 2014. Depositions of explanting physicians for both waves are to be completed by October 3rd, as well. (In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation - MDL No. 2326)
“Our Firm is representing numerous women who have allegedly suffered serious vaginal mesh complications due to products marketed by Boston Scientific. We are pleased to see these cases moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free legal reviews to women who suffered mesh erosion, pain, scarring, infection and other serious vaginal mesh complications, allegedly due to products marketed by a number of manufacturers.
Vaginal Mesh Lawsuits
According to court documents, Boston Scientific is named a defendant in nearly 12,000 vaginal mesh lawsuits pending in the Southern District of West Virginia. Among other things, the lawsuits claim that Boston Scientific’s pelvic mesh devices were defectively designed and manufactured, and caused thousands of women to suffer mesh erosion, organ damage, infections, bleeding, and other painful and debilitating vaginal mesh complications. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving on the Plaintiffs’ Steering Committee for the proceeding.
Mr. Grand is also serving on the Plaintiffs’ Steering Committees in several other multidistrict litigations established for transvaginal mesh lawsuits in the Southern District of West Virginia. These include proceedings involving American Medical Systems, Inc. (MDL No. 2325), C.R. Bard, Inc. (MDL 2326) and Ethicon, Inc. (MDL No. 2327).
Mr. Grand was also appointed Co-Liaison Counsel in two consolidated proceedings established for C.R. Bard and Ethicon mesh lawsuits in New Jersey’s Atlantic Superior Court. He was also a member of the trial team on the first Ethicon trial, which ended in March with an $11 million verdict for the Plaintiff. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)
Alleged victims of serious vaginal mesh complications may be entitled to file their own vaginal mesh lawsuit against the company that manufactured their implant. To learn more about transvaginal mesh, please visit Bernstein Liebhard LLP's website or the Firm's Facebook page: https://www.facebook.com/meshlawsuit. To obtain a free, confidential and no-obligation case review, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP